Differential accumulation of genetic and phenotypic changes in Venezuelan equine encephalitis virus and Japanese encephalitis virus following passage in vitro and in vivo

Virology

Volumn 415, Issue 1, 2011, Pages 20-29

  McCurdy, Kimberly ^a   Joyce, Julie ^a   Hamilton, Sara ^a   Nevins, Cheryl ^a   Sosna, William ^a   Puricelli, Kari ^a   Rayner, Jonathan O ^a  

^a MRIGlobal   (United States)

Author keywords

Alphavirus; Flaviviridae; Flavivirus; Genetic variation; Japanese encephalitis virus; JEV; Passage; Togaviridae; VEEV; Venezuelan equine encephalitis virus

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; PROLINE; THREONINE; VALINE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INVERTEBRATE; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; TISSUE CULTURE; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VERO CELL; VERTEBRATE; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS VIRULENCE;

ANIMALS; CELL LINE; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALITIS, JAPANESE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; MICE; MUTATION; PHENOTYPE; SEQUENCE ANALYSIS, RNA; SERIAL PASSAGE; VIRULENCE;

ALPHAVIRUS; ANIMALIA; ARBOVIRUS; FLAVIVIRIDAE; FLAVIVIRUS; INVERTEBRATA; JAPANESE ENCEPHALITIS VIRUS; MUS; TOGAVIRIDAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; VERTEBRATA;

EID: 79956194167     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.03.030     Document Type: Article

References (34)

1. Ada G. Vaccines and vaccination. N. Engl. J. Med. 2001, 345(14):1042-1053.
2. Bellamy R.J., Freedman A.R. Bioterrorism. QJM 2001, 94(4):227-234.
3. Butrapet S., Huang C.Y., Pierro D.J., Bhamarapravati N., Gubler D.J., Kinney R.M. Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J. Virol. 2000, 74(7):3011-3019.
4. Calisher C.H. Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 1994, 7(1):89-116.
5. Chambers T.J., Droll D.A., Jiang X., Wold W.S., Nickells J.A. JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. Virology 2007, 366(1):51-61.
6. Ciota A.T., Jia Y., Payne A.F., Jerzak G., Davis L.J., Young D.S., Ehrbar D., Kramer L.D. Experimental passage of St. Louis encephalitis virus in vivo in mosquitoes and chickens reveals evolutionarily significant virus characteristics. PLoS One 2009, 4(11):e7876.
7. Coffey L.L., Vasilakis N., Brault A.C., Powers A.M., Tripet F., Weaver S.C. Arbovirus evolution in vivo is constrained by host alternation. Proc. Natl. Acad. Sci. USA 2008, 105(19):6970-6975.
8. Drake J.W., Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 1999, 96(24):13910-13913.
9. Duarte E.A., Novella I.S., Weaver S.C., Domingo E., Wain-Hobson S., Clarke D.K., Moya A., Elena S.F., de la Torre J.C., Holland J.J. RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents Dis. 1994, 3(4):201-214.
10. Durbin A.P., Karron R.A., Sun W., Vaughn D.W., Reynolds M.J., Perreault J.R., Thumar B., Men R., Lai C.J., Elkins W.R., Chanock R.M., Murphy B.R., Whitehead S.S. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Am. J. Trop. Med. Hyg. 2001, 65(5):405-413.
11. Erlanger T.E., Weiss S., Keiser J., Utzinger J., Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg. Infect. Dis. 2009, 15(1):1-7.
12. Fernandez-Garcia M.D., Mazzon M., Jacobs M., Amara A. Pathogenesis of flavivirus infections: using and abusing the host cell. Cell Host Microbe 2009, 5(4):318-328.
13. Franz D.R., Jahrling P.B., McClain D.J., Hoover D.L., Byrne W.R., Pavlin J.A., Christopher G.W., Cieslak T.J., Friedlander A.M., Eitzen E.M. Clinical recognition and management of patients exposed to biological warfare agents. Clin. Lab. Med. 2001, 21(3):435-473.
14. Geiss B.J., Stahla H., Hannah A.M., Gari H.H., Keenan S.M. Focus on flaviviruses: current and future drug targets. Future Med. Chem. 2009, 1(2):327.
15. Gorchakov R., Frolova E., Sawicki S., Atasheva S., Sawicki D., Frolov I. A new role for ns polyprotein cleavage in Sindbis virus replication. J. Virol. 2008, 82(13):6218-6231.
16. Gould E.A., Coutard B., Malet H., Morin B., Jamal S., Weaver S., Gorbalenya A., Moureau G., Baronti C., Delogu I., Forrester N., Khasnatinov M., Gritsun T., de Lamballerie X., Canard B. Understanding the alphaviruses: Recent research on important emerging pathogens and progress towards their control. Antiviral Res. 2009.
17. Greene I.P., Wang E., Deardorff E.R., Milleron R., Domingo E., Weaver S.C. Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells. J. Virol. 2005, 79(22):14253-14260.
18. Jenkins G.M., Rambaut A., Pybus O.G., Holmes E.C. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J. Mol. Evol. 2002, 54(2):156-165.
19. Jerzak G.V., Bernard K., Kramer L.D., Shi P.Y., Ebel G.D. The West Nile virus mutant spectrum is host-dependant and a determinant of mortality in mice. Virology 2007, 360(2):469-476.
20. Jerzak G.V., Brown I., Shi P.Y., Kramer L.D., Ebel G.D. Genetic diversity and purifying selection in West Nile virus populations are maintained during host switching. Virology 2008, 374(2):256-260.
21. Jose J., Snyder J.E., Kuhn R.J. A structural and functional perspective of alphavirus replication and assembly. Future Microbiol. 2009, 4:837-856.
22. Kadlec R.P., Zelicoff A.P., Vrtis A.M. Biological weapons control. Prospects and implications for the future. JAMA 1997, 278(5):351-356.
23. Kinney R.M., Chang G.J., Tsuchiya K.R., Sneider J.M., Roehrig J.T., Woodward T.M., Trent D.W. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J. Virol. 1993, 67(3):1269-1277.
24. Lowry P.W., Truong D.H., Hinh L.D., Ladinsky J.L., Karabatsos N., Cropp C.B., Martin D., Gubler D.J. Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995. Am. J. Trop. Med. Hyg. 1998, 58(3):324-329.
25. Lustig S., Halevy M., Ben-Nathan D., Akov Y. A novel variant of Sindbis virus is both neurovirulent and neuroinvasive in adult mice. Arch. Virol. 1992, 122(3-4):237-248.
26. Mackenzie J.S., Gubler D.J., Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 2004, 10(12 Suppl):S98-S109.
27. Ni H., Chang G.J., Xie H., Trent D.W., Barrett A.D. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J. Gen. Virol. 1995, 76(Pt 2):409-413.
28. Nitayaphan S., Grant J.A., Chang G.J., Trent D.W. Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology 1990, 177(2):541-552.
29. Shirako Y., Strauss J.H. Cleavage between nsP1 and nsP2 initiates the processing pathway of Sindbis virus nonstructural polyprotein P123. Virology 1990, 177(1):54-64.
30. Steinhauer D.A., Domingo E., Holland J.J. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene 1992, 122(2):281-288.
31. Vasilakis N., Deardorff E.R., Kenney J.L., Rossi S.L., Hanley K.A., Weaver S.C. Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells. PLoS Pathog. 2009, 5(6):e1000467.
32. Weaver S.C., Brault A.C., Kang W., Holland J.J. Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J. Virol. 1999, 73(5):4316-4326.
33. Yu Y. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 2010, 28(21):3635-3641.
34. Zacks M.A., Paessler S. Encephalitic alphaviruses. Vet. Microbiol. 2010, 140(3-4):281-286.